月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE（每份年报一根整柱，柱宽 = 生效期：报告期 + 4 个月起）
加载中…
获利能力 Profitability (单位：美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率（ROE） | - | 26.48% | 29.60% | 31.34% | 39.62% | 45.95% | 54.90% | 60.54% | 63.92% | 79.90% | 82.23% | 80.20% | 76.00% | 71.19% | 69.70% | 71.24% | 72.00% | 88.07% | 80.78% | 60.70% | 35.65% | 33.49% |
| 总资产收益率（ROA） | - | 17.85% | 19.06% | 19.67% | 23.46% | 26.43% | 32.64% | 35.80% | 34.36% | 37.97% | 38.88% | 37.25% | 34.87% | 31.01% | 29.08% | 24.55% | 23.01% | 26.61% | 21.69% | 18.87% | 11.52% | 11.69% |
| 毛利率 | 75.26% | 76.59% | 77.81% | 79.56% | 80.78% | 81.03% | 82.74% | 83.08% | 83.60% | 85.00% | 84.63% | 84.21% | 84.25% | 83.54% | 83.51% | 83.20% | 83.92% | 84.60% | 84.67% | 80.98% | 83.39% | 82.49% |
| 净利率 | 16.65% | 20.37% | 21.17% | 21.08% | 23.70% | 25.77% | 27.47% | 30.13% | 29.82% | 32.30% | 33.93% | 34.14% | 34.54% | 31.92% | 33.19% | 33.92% | 31.38% | 36.03% | 34.78% | 33.14% | 35.84% | 39.67% |
| 每股收益（EPS） | 10.05 | 13.49 | 15.66 | 17.97 | 24.81 | 6.05 | 7.82 | 9.40 | 10.10 | 13.56 | 14.99 | 15.42 | 15.96 | 16.41 | 18.05 | 10.40 | 12.26 | 18.67 | 22.67 | 23.06 | 12.50 | 15.67 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | - | 10.10% | 17.35% | - | - | 20.72% | 17.59% | 15.25% | 18.68% | 18.43% | 19.16% | 18.42% | 14.12% | 12.32% | 8.80% | - | - | - | - | - | - | - |
| 负债占总资产比率 | - | 32.58% | 34.83% | 34.72% | 39.80% | 42.12% | 38.13% | 39.48% | 47.71% | 48.83% | 53.59% | 51.33% | 53.20% | 54.15% | 56.30% | 63.63% | 65.40% | 66.12% | 69.18% | 64.26% | 65.14% | 62.81% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | - | 6.87 | 6.92 | 7.23 | 7.15 | 7.10 | 8.09 | 7.66 | 6.81 | 6.97 | 5.52 | 5.54 | 4.91 | 4.90 | 4.58 | 3.46 | 3.50 | 3.59 | 4.04 | 4.36 | 2.23 | 1.97 |
| 平均收现日数 | - | 53 天 | 53 天 | 50 天 | 51 天 | 51 天 | 45 天 | 48 天 | 54 天 | 52 天 | 66 天 | 66 天 | 74 天 | 75 天 | 80 天 | 105 天 | 104 天 | 102 天 | 90 天 | 84 天 | 164 天 | 185 天 |
| 固定资产周转率(次) | - | 0.4687 | 0.4092 | 0.3764 | 0.3374 | 0.3155 | 0.2760 | 0.2618 | 0.2605 | 0.2367 | 0.2700 | 0.3156 | 0.3746 | 0.4143 | 0.3960 | 0.3932 | 0.3768 | 0.3916 | 0.5567 | 0.6742 | 1.1666 | 1.3220 |
| 总资产周转率 | - | 87.64% | 90.02% | 93.31% | 98.98% | 102.55% | 118.82% | 118.82% | 115.24% | 117.57% | 114.60% | 109.13% | 100.96% | 97.14% | 87.60% | 72.39% | 73.35% | 73.85% | 62.37% | 56.93% | 32.14% | 29.47% |
现金流量 Cash Flow (单位：亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | - | 48.23 | 87.81 | - | - | 134.08 | 115.53 | 107.28 | 143.96 | 169.23 | 186.90 | 188.52 | 156.38 | 154.75 | 127.57 | - | - | - | - | - | - | - |
| 净利润 | 64.52 | 85.22 | 96.45 | 107.68 | 144.03 | 170.97 | 214.32 | 251.84 | 264.81 | 348.60 | 379.25 | 381.30 | 386.28 | 389.51 | 421.38 | 477.57 | 555.25 | 836.83 | 1009.88 | 1024.34 | 555.37 | 695.46 |
| 经营活动现金流量 | 77.38 | 99.87 | 128.63 | 153.78 | 196.79 | 213.74 | 222.14 | 259.42 | 316.92 | 382.87 | 483.14 | 411.68 | 446.16 | 467.82 | 519.51 | 550.00 | 788.87 | 1089.08 | 1209.68 | 1191.02 | 665.04 | 792.83 |
| 投资活动现金流量 | -25.17 | -15.16 | -13.82 | -30.46 | -55.79 | -34.59 | -40.70 | -27.73 | -20.64 | -60.98 | -67.90 | -65.71 | -120.80 | -115.09 | -224.36 | -316.05 | -249.18 | -438.92 | -1288.95 | -791.58 | -200.97 | -244.76 |
| 筹资活动现金流量 | -47.58 | -68.33 | -73.70 | -100.45 | -132.20 | -168.02 | -201.40 | -236.39 | -265.33 | -301.01 | -388.87 | -356.89 | -345.21 | -354.84 | -322.44 | -254.93 | -517.97 | -631.58 | 87.35 | -284.08 | -427.31 | -365.65 |
| 净现金流量 | 5.02 | 16.32 | 41.11 | 22.87 | 9.26 | 10.97 | -20.04 | -5.40 | 31.63 | 21.74 | 26.11 | -13.03 | -19.41 | -2.18 | -27.29 | -20.98 | 21.72 | 18.58 | 8.08 | 115.36 | 36.76 | 182.42 |
右侧两列为报告期累计口径同比（左：去年同期同一期次，右：最近一期季报，年报期次已在左侧列展示）；周转率类指标为报告期累计值，未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD